LOS ANGELES – In early 2022, around the time the Omicron variant started driving a new surge in COVID-19 cases, researchers at James DeGregori’s University of Colorado Anschutz lab noticed something ...

The OPTIMA trial (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis) was designed to reduce the use of unnecessary chemotherapy for people with newly diagnosed ...

Data presented at ASCO 2026 highlighted the growing role of genomic testing to guide chemotherapy de-escalation and the efficacy of novel adjuvant therapies in early-stage breast cancer. Data ...

Using tissue samples, pathology images and clinical data from 672 patients, researchers trained AI to uncover information about a tumor's biology. Drawing on multiple de-identified datasets, including ...

CRC continues to be one of the leading causes of cancer-related mortality worldwide, with approximately 154,270 new cases expected in the United States in 2025 (ref. 1). The standard of care (SoC) for ...

Bitcoin processed more than 820,000 transactions, its highest daily count in over two years, with Rune-related activity accounting for a significant share of network usage. Transactions carrying Rune ...

Detailed price information for Elicio Therapeutics Inc (ELTX-Q) from The Globe and Mail including charting and trades.

Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 05 4 June 2026 Worldwide ...

In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help ...

Data sources Database searches: (1) inception to 2011 (original), and (2) 2011 to December 2018 (update). Citation tracking, manual reference and ahead of press searches. Eligibility criteria for ...

A small but striking study is giving cancer researchers another reason to closely watch a new kind of treatment. An experimental personalized mRNA vaccine showed lasting results in some patients with ...